Study Evaluating The PK And Safety Of Neratinib In Healthy Subjects And Subjects With Chronic Liver Disease

Mise à jour : Il y a 4 ans
Référence : NCT00781430

Femme et Homme

Extrait

The purpose of this study is to assess the pharmacokinetics of neratinib and to assess the safety and tolerability of neratinib in healthy subjects and subjects with chronic liver disease.


Critère d'inclusion

  • Hepatic Insufficiency

Liens